{
    "nct_id": "NCT05248256",
    "official_title": "Vertebral Bone Marrow in Lung Cancer Attention Trial (VMAT)",
    "inclusion_criteria": "* Adult patient > 18 years\n* Patients with AJCC (American Joint Committee on Cancer) 8 T1-T4, N1-N3, M0 stage IIIA-IIIC NSCLC (non small cell lung cancer)\n* Patients with oligometastatic disease stage IV, M1 disease, in which definitive concurrent chemoradiotherapy to the thorax is planned\n* CBC/CMP within these limits\n* Absolute lymphocyte count>500/ml\n* Hemoglobin>8 g/dL\n* AST (aspartate aminotransferase)/ALT (alanine transaminase) <2.5 times of ULN\n* Eastern Cooperative Oncology Group (ECOG) 0-2\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* History of thoracic irradiation\n* History of palliative radiation for the current malignancy under consideration\n* Patients not being treated with definitive standard of care to the chest\n* History of bone marrow disease and or leukemia\n* History of prior cytotoxic chemotherapy for a disease other than for the current malignancy\n* Polymetastatic disease, defined here as â‰¥3 or more extrathoracic metastases\n* Administration of concurrent immunotherapy during radiation therapy, either as part of another clinical trial or otherwise",
    "miscellaneous_criteria": ""
}